Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.
about
Leveraging MEDLINE indexing for pharmacovigilance - Inherent limitations and mitigation strategies.Antibiotic-induced neurotoxicity.Tumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system.bloodstream infection preceding the diagnosis of rectal carcinoma
P2860
Fluoroquinolone-associated myasthenia gravis exacerbation: evaluation of postmarketing reports from the US FDA adverse event reporting system and a literature review.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Fluoroquinolone-associated mya ...... ystem and a literature review.
@ast
Fluoroquinolone-associated mya ...... ystem and a literature review.
@en
Fluoroquinolone-associated mya ...... ystem and a literature review.
@nl
type
label
Fluoroquinolone-associated mya ...... ystem and a literature review.
@ast
Fluoroquinolone-associated mya ...... ystem and a literature review.
@en
Fluoroquinolone-associated mya ...... ystem and a literature review.
@nl
prefLabel
Fluoroquinolone-associated mya ...... ystem and a literature review.
@ast
Fluoroquinolone-associated mya ...... ystem and a literature review.
@en
Fluoroquinolone-associated mya ...... ystem and a literature review.
@nl
P2093
P2860
P1433
P1476
Fluoroquinolone-associated mya ...... ystem and a literature review.
@en
P2093
Alfred Sorbello
Robert M Boucher
S Christopher Jones
P2860
P304
P356
10.2165/11593110-000000000-00000
P577
2011-10-01T00:00:00Z
P6179
1018270575